Computational insights into the inhibitory mechanism of human AKT1 by an orally active inhibitor, MK-2206.
The AKT signaling pathway has been identified as an important target for cancer therapy. Among small-molecule inhibitors of AKT that have shown tremendous potential in inhibiting cancer, MK-2206 is a highly potent, selective and orally active allosteric inhibitor. Promising preclinical anticancer re...
Saved in:
Main Authors: | , , , , |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2014
|
Subjects: | |
Online Access: | https://doaj.org/article/cdbecee0d83e46b68810817fb3f3c93b |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|